ストックスクリーナーアプリを入手
39.73
0.89%
0.35
Xenon Pharmaceuticals Inc (XENE) 最新ニュース
Xenon Pharmaceuticals (XENE) Projected to Post Earnings on Thursday - Defense World
TimesSquare Capital Management LLC Boosts Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
Xenon Pharmaceuticals CEO sells shares worth $2.21 million - MSN
Xenon Pharmaceuticals to Announce Q4 and Full Year 2024 Financial Results - TipRanks
Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025 - The Manila Times
Can Xenon's Promising Epilepsy Drug Pipeline Deliver? Q4 Results Will Tell - StockTitan
Epilepsy Market Assessment in the 7MM by 2034 — A Detailed Analysis of Growth Prospects Across Different Types | DelveInsight - GlobeNewswire Inc.
(XENE) Trading Advice - Stock Traders Daily
Traders Purchase Large Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - Armenian Reporter
Investors Purchase High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - Defense World
Deutsche Bank Aktiengesellschaft Begins Coverage on Xenon Pharmaceuticals (NASDAQ:XENE) - MarketBeat
Analysts Set Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Price Target at $56.00 - MarketBeat
Xenon Pharmaceuticals (NASDAQ:XENE) Coverage Initiated at Deutsche Bank Aktiengesellschaft - Defense World
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives $56.00 Average Target Price from Analysts - Defense World
abrdn plc Boosts Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
Deutsche Bank Initiates Coverage of Xenon Pharmaceuticals (XENE) with Buy Recommendation - Nasdaq
XENE stock rated an Outperform by Raymond James - Knox Daily
Deutsche Bank Initiates Coverage on Xenon Pharmaceuticals With Buy Rating, $67 Price Target - Marketscreener.com
(XENE) Trading Signals - Stock Traders Daily
Xenon Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:XENE) - MarketBeat
Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Purchased by Jennison Associates LLC - MarketBeat
Blue Trust Inc. Raises Stock Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Xenon Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:XENE) - Defense World
FY2025 EPS Estimate for Xenon Pharmaceuticals Cut by Analyst - MarketBeat
SG Americas Securities LLC Buys 5,577 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Leerink Partnrs Has Bearish Outlook for XENE FY2025 Earnings - Defense World
Learn to Evaluate (XENE) using the Charts - Stock Traders Daily
2,569 Shares in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Acquired by Avior Wealth Management LLC - Defense World
Ian Mortimer Sells 22,468 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Stock - MarketBeat
Wedbush Lowers Earnings Estimates for Xenon Pharmaceuticals - Defense World
Q1 EPS Estimates for Xenon Pharmaceuticals Cut by Wedbush - MarketBeat
FY2029 Earnings Forecast for XENE Issued By Wedbush - Defense World
Cantor Fitzgerald Predicts XENE FY2025 Earnings - Defense World
Cantor Fitzgerald Estimates XENE FY2025 Earnings - MarketBeat
Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE) - Defense World
Traders Buy Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - MarketBeat
Epidemic Keratoconjunctivitis Market Expected to Reach Huge - openPR
Xenon Pharmaceuticals announces executive changes - MSN
Assenagon Asset Management S.A. Has $9.35 Million Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World
Assenagon Asset Management S.A. Increases Stock Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - MarketBeat
How To Trade (XENE) - Stock Traders Daily
Xenon Pharmaceuticals announces executive changes By Investing.com - Investing.com Australia
Xenon Pharmaceuticals’ CCO Departure and Consultancy Role - MSN
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):